Ann Marilyn Leitch

Ann Marilyn Leitch

Auto-generated profile, based on publicly available information

Ann Marilyn Leitch

Department of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2010 in Annals of Surgical Oncology
Verified
Journal Article
Open access
PDF file
LWLee G. Wilke
Lee G. Wilke
KBKarla V. Ballman
Karla V. Ballman
LMLinda M. McCall
Linda M. McCall
AGArmando E. Giuliano
Armando E. Giuliano
PWPat Whitworth
Pat Whitworth
KHKelly K. Hunt
Kelly K. Hunt
In 2007, the National Quality Forum (NQF) released four performance measures for the treatment of breast cancer. We proposed to study the degree of adherence with these measures among participating institutions in a multi-institutional trial.

1 January 2023 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
CJChristopher Johns
Christopher Johns
AYAllen Yen
Allen Yen
ARAsal Rahimi
Asal Rahimi
YLYu-Lun Liu
Yu-Lun Liu
ALAnn Marilyn Leitch
Ann Marilyn Leitch
DKD. W. Nathan Kim
D. W. Nathan Kim
Johns C, et al. J Breast Cancer. 2023 Jan;26:e3. https://doi.org/10.4048/jbc.2023.26.e3

30 March 2023 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
CJChristopher Johns
Christopher Johns
SMSteven K. Montalvo
Steven K. Montalvo
MCM’kAy Cauble
M’kAy Cauble
YLYu-Lun Liu
Yu-Lun Liu
SASean All
Sean All
DKD. W. Nathan Kim
D. W. Nathan Kim

1 December 2015 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
SMSayantan Maji
Sayantan Maji
ALAnn Marilyn Leitch
Ann Marilyn Leitch
IAIrina Akopova
Irina Akopova
PNPhung Nguyen
Phung Nguyen
Jamboor VishwanathaJamboor Vishwanatha
Jamboor Vishwanatha
Background: Early detection of cancer using circulating biomarkers is a realistic possibility with the discovery of exosomes. Cells under both physiological and pathological conditions secrete a wide array of membranous vesicles containing specific protein and RNA signatures. Exosomes, which are 40-100 nm in size, comprise a major portion of these vesicles. Exosomes play important roles in promoting tumor progression and metastasis, but the mechanisms by which they act are not yet understood. Annexin A2 (AnxA2) is a 36 kDa calcium dependent phospholipid-binding protein up-regulated in many cancer types and promotes tumorigenesis and angiogenesis by acting as a receptor for angiostatin and tissue plasminogen activator (t-PA) leading to plasmin mediated angiogenesis and metastasis. Recently, it was found that AnxA2 is one of the most commonly expressed proteins in exosomes, but its function has never been characterized. We propose to explore the correlation and functionality of exosome associated AnxA2 (exo-AnxA2) in breast cancer.